Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist/antagonist activity
文献类型：期刊论文
| 作者 | Sun, Jian-Feng1,2; Wang, Yu-Hua3; Chai, Jing-Rui1; Li, Fu-Ying1; Hang, Ai4; Lu, Gang1; Tao, Yi-Min1; Cheng, Yun1; Chi, Zhi-Qiang1 ; Neumeyer, John L.5
|
| 刊名 | EUROPEAN JOURNAL OF PHARMACOLOGY
 |
| 出版日期 | 2014-10-05 |
| 卷号 | 740页码:455-463 |
| ISSN号 | 0014-2999 |
| 关键词 | kappa against and mu agonistfantagonist Antinociception Sedation CPP Heroin self-administration Reinstatement of drug seeking behavior |
| DOI | 10.1016/j.ejphar.2014.06.045 |
| 文献子类 | Article |
| 英文摘要 | We previously reported that the kappa agonists with mixed mu activity could attenuate heroin selfadministration with less potential to develop tolerance. The present study further investigated the effects of (-)-3-N-Ethylamino-thiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride (ATPM-ET), a kappa agonist and mu agonistiantagonist, on the acquisition and reinstatement of morphine-induced conditioned place preference (CPP), heroin self-administration and heroin-primed reinstatement of drug seeking behavior. We found that ATPM-ET produced a longer duration of potent antinociceptive effects with less side effect of sedation. More importantly, ATPM-ET attenuated the acquisition of morphine induced CPP, without affecting the reinstatement of morphine CPP. Furthermore, ATPM-ET significantly inhibited heroin self administration and the reinstatement of heroin primed drug seeking behavior. Taken together, ATPM-ET, a novel kappa agonist and mu agonist/antagonist may have utility for the treatment of drug dependence. (C) 2014 Elsevier B.V. All rights reserved. |
| WOS关键词 | CONDITIONED PLACE PREFERENCE ; RHESUS-MONKEYS ; INDUCED REINSTATEMENT ; DRUG-SEEKING ; COCAINE ; MORPHINE ; HEROIN ; RECEPTOR ; RATS ; BEHAVIOR |
| 资助项目 | Ministry of Science and Technology of China[2009CB522005] ; Ministry of Science and Technology of China[2013CB835100] ; Ministry of Science and Technology of China[2012ZX09301001-005] ; Ministry of Science and Technology of China[2012BAI01B00] ; National Natural Science Foundation of China[81130087] ; National Natural Science Foundation of China[91232716] ; Committee of Science and Technology of Shanghai[13JC140680] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| 出版者 | ELSEVIER SCIENCE BV |
| WOS记录号 | WOS:000341163700055 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/276873]  |
| 专题 | 药理学第二研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Liu, Jing-Gen |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; 2.Jilin Univ, Dept Physiol, Norman Bethune Med Coll, Changchun 130021, Peoples R China; 3.Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210046, Jiangsu, Peoples R China; 4.China Pharmaceut Univ, Dept Pharmacol, Nanjing 211198, Jiangsu, Peoples R China; 5.Harvard Univ, Sch Med, Alcohol & Drug Abuse Res Ctr, McLean Hosp, Boston, MA 02478 USA |
| 推荐引用方式 GB/T 7714 | Sun, Jian-Feng,Wang, Yu-Hua,Chai, Jing-Rui,et al. Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist/antagonist activity[J]. EUROPEAN JOURNAL OF PHARMACOLOGY,2014,740:455-463. |
| APA | Sun, Jian-Feng.,Wang, Yu-Hua.,Chai, Jing-Rui.,Li, Fu-Ying.,Hang, Ai.,...&Wang, Yu-Jun.(2014).Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist/antagonist activity.EUROPEAN JOURNAL OF PHARMACOLOGY,740,455-463. |
| MLA | Sun, Jian-Feng,et al."Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist/antagonist activity".EUROPEAN JOURNAL OF PHARMACOLOGY 740(2014):455-463. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。